Searched for
PENTASA
Sun Pharma shares in focus ahead of Q2 results todaySun Pharma Share Price: Sun Pharma is set to announce its Q2 FY25 results, with revenue growth expected to be driven by domestic business a...- Q2 results today: Airtel, Sun Pharma among 173 companies to announce earnings on MondayToday, 173 companies will disclose their Q2 earnings, including Airtel, Sun Pharma, and Adani Power. Bharti Airtel is anticipated to post r...
- Sun Pharma Q2 Results Preview: PAT may rise 25% YoY; healthy revenue growth seenRevenue from operations is likely to jump 10% year-on-year, according to the average estimate of four brokerages. Meanwhile, net profit for...
- Sun Pharma Q3 preview: Consolidated PAT may rise 8% YoY amid moderate revenue growthSun Pharmaceutical Industries Ltd is expected to report single-digit revenue growth for Q3 earnings, with moderate sales in the US and Indi...
- Sun Pharma Q3 Preview: Sales likely to rise but profit may fall YoYAccording to an ETNow poll, the drugmaker’s consolidated revenue for the quarter ended December is seen rising 12.5% on-year to Rs 11,100 c...
- Better pill! Jefferies gives a double upgrade to Sun Pharma stockSun Pharma performance has been a mixed bag in the near term as the shares dropped 13 per cent in the last month, whereas rose close to 7 p...
- Sensex hits a fresh 52-week low but these stocks look attractively valuedS Naren of ICICI Prudential MF said the market has not reached a point of maximum pessimism as yet and believes equities would be very attr...
- Sun Pharma jumps 4% on receiving USFDA nod for Mesalamine capsuleThe company has received approval from the US Food and Drug Administration (USFDA) for the product, a generic version of Pentasa extended r...
- Sun Pharma gets USFDA nod for generic drug Mesalamine extended release capsulesThe company has received approval from the US Food and Drug Administration (USFDA) for the product, a generic version of Pentasa extended r...
Load More
